To determine the incidence of scalene node metastasis from carcinoma of the cervix uteri, all patients with advanced carcinoma of the cervix who underwent scalene node biopsy as part of a pretreatment evaluation at the University of Iowa Hospitals and Clinics have been reviewed. In 40 patients, lef
Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder
β Scribed by Mr V. K. Kapoor; R. Pradeep; S. P. Haribhakti; V. Singh; S. S. Sikora; R. Saxena; S. P. Kaushik
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 354 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
β¦ Synopsis
The majority of patients with advanced carcinoma of the gallbladder have irresectable disease and require palliation for jaundice, pruritus and cholangitis. Intrahepatic segment 111 cholangiojejunostomy has been described for palliation of high biliary obstruction in these patients. Forty-one patients with stage IV gallbladder cancer underwent intrahepatic segment I11 cholangiojejunostomy. Subsequent jaundice, pruritus and cholangitis were documented; liver function tests and isotope hepatobiliary scans were performed. All patients had jaundice, 29 had pruritus and 12 had cholangitis. Postoperative complications included anastomotic leak in six patients and wound infection in six. Five patients died within 30 days of operation. Thirty-two patients were available for follow-up. The procedure failed to relieve jaundice, pruritus or cholangitis in four patients; 18 were free of jaundice, pruritus and cholangitis until death or last follow-up, and ten had recurrent jaundice or cholangitis. Isotope scanning was found to be useful to predict success of the procedure. Intrahepatic segment I11 cholangiojejunostomy provided excellent palliation from jaundice, pruritus and cholangitis with acceptable mortality and morbidity rates in patients with advanced carcinoma of the gallbladder.
Carcinoma of the gallbladder is the commonest biliary tract malignancy. Unfortunately most patients have advanced disease at the time of diagnosis. Jaundice is common, and pruritus and cholangitis are distressing associated features. A large single-centre experience with intrahepatic segment I11 cholangiojejunostomy for palliation of these symptoms in patients with advanced gallbladder cancer is presented.
π SIMILAR VOLUMES
I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o
## Background: The authors designed this randomized, controlled trial to assess whether dose intensification of a cisplatin-etoposide combination (pe), achieved by shortening the interval between chemotherapy cycles, would improve response rate and survival. the maximum tolerated dose of pe was adm
## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv